Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob E Corn

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Nature Biotechnology|November 28, 2024
Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterationsGrégoire Cullot, Eric J Aird, Moritz F Schlapansky, et al.
Neuro-Oncology|July 8, 2022
Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactionsMarcel Buehler, Xiao Yi, Weigang Ge, et al.
Nature Communications|May 2, 2020
Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repairBeeke Wienert, David N Nguyen, Alexis Guenther, et al.
Science Translational Medicine|October 14, 2016
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cellsMark A DeWitt, Wendy Magis, Nicolas L Bray, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2025
Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cellsThomas Wisbech Skov, Jonas Holst Wolff, Didde Haslund, et al.
Molecular Cell|July 1, 2020
The Histone Chaperone FACT Induces Cas9 Multi-turnover Behavior and Modifies Genome Manipulation in Human CellsAlan S Wang, Leo C Chen, R Alex Wu, et al.
Nature Communications|February 25, 2026
ERCC6L2 ensures repair fidelity for staggered-end DNA double-strand breaksEric J Aird, Almudena Serrano-Benitez, Sebastian M Siegner, et al.
Science (New York, N.Y.)|February 5, 2026
Programmable genome editing in human cells using RNA-guided bridge recombinasesOana Pelea, András Tálas, Javier Fernández Carrera, et al.
Science (New York, N.Y.)|March 21, 2015
Biotechnology. A prudent path forward for genomic engineering and germline gene modificationDavid Baltimore, Paul Berg, Michael Botchan, et al.
Nature|January 29, 2025
C-terminal amides mark proteins for degradation via SCF-FBXO31Matthias F Muhar, Jakob Farnung, Martina Cernakova, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Nature Biotechnology|November 28, 2024
Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterationsGrégoire Cullot, Eric J Aird, Moritz F Schlapansky, et al.
Neuro-Oncology|July 8, 2022
Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactionsMarcel Buehler, Xiao Yi, Weigang Ge, et al.
Nature Communications|May 2, 2020
Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repairBeeke Wienert, David N Nguyen, Alexis Guenther, et al.
Science Translational Medicine|October 14, 2016
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cellsMark A DeWitt, Wendy Magis, Nicolas L Bray, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2025
Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cellsThomas Wisbech Skov, Jonas Holst Wolff, Didde Haslund, et al.
Molecular Cell|July 1, 2020
The Histone Chaperone FACT Induces Cas9 Multi-turnover Behavior and Modifies Genome Manipulation in Human CellsAlan S Wang, Leo C Chen, R Alex Wu, et al.
Nature Communications|February 25, 2026
ERCC6L2 ensures repair fidelity for staggered-end DNA double-strand breaksEric J Aird, Almudena Serrano-Benitez, Sebastian M Siegner, et al.
Science (New York, N.Y.)|February 5, 2026
Programmable genome editing in human cells using RNA-guided bridge recombinasesOana Pelea, András Tálas, Javier Fernández Carrera, et al.
Science (New York, N.Y.)|March 21, 2015
Biotechnology. A prudent path forward for genomic engineering and germline gene modificationDavid Baltimore, Paul Berg, Michael Botchan, et al.
Nature|January 29, 2025
C-terminal amides mark proteins for degradation via SCF-FBXO31Matthias F Muhar, Jakob Farnung, Martina Cernakova, et al.
Pageof 10